6CM
RNAM

683 Capital Management’s Avidity Biosciences RNAM Stock Holding History

683 Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70,000
Closed -$5.05M – 263
2025
Q4 		$5.05M Buy
+70,000
New +$4.52M 0.22% 84

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

683 Capital Management's RNAM Position: Q1 2026 in Review

683 Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 70,000 shares — an estimated $5.05M sold.

683 Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $5.05M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • 683 Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • 683 Capital Management sold 70,000 Avidity Biosciences shares in Q1 2026, an estimated $5.05M.
  • 683 Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • 683 Capital Management's Avidity Biosciences position peaked at $5.05M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.